NEWTOWN, Pa., May 19, 2023 Helius Medical Technologies, Inc. , a neurotech company focused on neurological wellness, today announced that, effective May 18, 2023, its independent directors. | June 11, 2023
Helius Medical Technologies (NASDAQ:HSDT – Get Rating) had its price target cut by LADENBURG THALM/SH SH from $2.00 to $1.70 in a research note issued to investors on Friday, The Fly reports. Helius Medical Technologies Stock Performance Shares of NASDAQ HSDT opened at $0.15 on Friday. The stock has a market capitalization of $4.23 million, […]
Operator: Good day, and thank you for standing by. Welcome to the Helius Medical Technologies, Inc. Quarter One 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT an annual and special meeting of the holders of common shares in the capital of Profound. | April 25, 2023
Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Rating) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 369,700 shares, a drop of 7.1% from the March 15th total of 398,000 shares. Based on an average trading volume of 502,600 shares, the short-interest ratio […]